Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Cyberonics receives FDA approval for Vagus Nerve Stimulation Device

Cyberonics has received approval from the US Food and Drug Administration (FDA) for AspireHC (High Capacity) generator for use in vagus nerve stimulation (VNS) therapy system.

The VNS therapy system is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression.

The system uses implanted medical device that delivers electrical pulsed signals to the vagus nerve.

The AspireHC generator, which represents fifth generation of VNS Therapy technology, features greater functionality, improved electronics and simplified features for programming.